 | • レポートコード：MRC2-11QY04016 • 出版社/出版日：QYResearch / 2020年11月20日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、133ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：ヘルスケア |
| Single User | ￥585,000 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥877,500 (USD5,850) | ▷ お問い合わせ |
| Enterprise License | ￥1,170,000 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料はNSAID治療薬のグローバル市場について調査・分析したレポートです。種類別（イブプロフェン、ナプロキセン）市場規模、用途別（病院、診療所、ドラッグストア）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）市場規模データ、主な企業情報と企業別市場シェア等が収録されています。 ・調査範囲 ・エグゼクティブサマリー ・企業別NSAID治療薬の競争状況、市場シェア ・世界のNSAID治療薬市場：種類別市場規模 2015年-2020年（イブプロフェン、ナプロキセン） ・世界のNSAID治療薬市場：種類別市場規模予測 2021年-2026年（イブプロフェン、ナプロキセン） ・世界のNSAID治療薬市場：用途別市場規模 2015年-2020年（病院、診療所、ドラッグストア） ・世界のNSAID治療薬市場：用途別市場規模予測 2021年-2026年（病院、診療所、ドラッグストア） ・北米のNSAID治療薬市場分析：米国、カナダ ・ヨーロッパのNSAID治療薬市場分析：ドイツ、フランス、イギリス、イタリア、ロシア等 ・アジアのNSAID治療薬市場分析：日本、中国、韓国、インド、オーストラリア、台湾等 ・中南米のNSAID治療薬市場分析：メキシコ、ブラジル、アルゼンチン等 ・中東・アフリカのNSAID治療薬市場分析：トルコ、サウジアラビア、UAE等 ・企業情報（企業概要、製品概要、販売量、企業動向） - 掲載企業（変更可能性あり）：Pfizer、GSK、Grunenthal、Bayer、Sanofi、Eli Lilly、AstraZeneca、Endo、Merck、Depomed、Yunnan Baiyao、Teva、J&J、Allergan、Purdue ・地域別市場規模予測（2021年-2026年）：北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場 ・市場機会、課題、リスク、環境分析 ・バリューチェーン、販売チャネル分析 ・調査の結論 |
Market Analysis and Insights: Global NSAIDs Drug Market
The global NSAIDs Drug market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026.
Global NSAIDs Drug Scope and Market Size
NSAIDs Drug market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global NSAIDs Drug market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.
The key players covered in this study
Pfizer
GSK
Grunenthal
Bayer
Sanofi
Eli Lilly
AstraZeneca
Endo
Merck
Depomed
Yunnan Baiyao
Teva
J&J
Allergan
Purdue
Market segment by Type, the product can be split into
Ibuprofen
Naproxen
Market segment by Application, split into
Hospitals
Clinics
Drugstores
Market segment by Regions/Countries, this report covers
North America
Europe
China
Japan
Southeast Asia
India
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by NSAIDs Drug Revenue
1.4 Market by Type
1.4.1 Global NSAIDs Drug Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Ibuprofen
1.4.3 Naproxen
1.5 Market by Application
1.5.1 Global NSAIDs Drug Market Share by Application: 2020 VS 2026
1.5.2 Hospitals
1.5.3 Clinics
1.5.4 Drugstores
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends
2.1 Global NSAIDs Drug Market Perspective (2015-2026)
2.2 Global NSAIDs Drug Growth Trends by Regions
2.2.1 NSAIDs Drug Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 NSAIDs Drug Historic Market Share by Regions (2015-2020)
2.2.3 NSAIDs Drug Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
2.3.5 NSAIDs Drug Market Growth Strategy
2.3.6 Primary Interviews with Key NSAIDs Drug Players (Opinion Leaders)
3 Competition Landscape by Key Players
3.1 Global Top NSAIDs Drug Players by Market Size
3.1.1 Global Top NSAIDs Drug Players by Revenue (2015-2020)
3.1.2 Global NSAIDs Drug Revenue Market Share by Players (2015-2020)
3.1.3 Global NSAIDs Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global NSAIDs Drug Market Concentration Ratio
3.2.1 Global NSAIDs Drug Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by NSAIDs Drug Revenue in 2019
3.3 NSAIDs Drug Key Players Head office and Area Served
3.4 Key Players NSAIDs Drug Product Solution and Service
3.5 Date of Enter into NSAIDs Drug Market
3.6 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global NSAIDs Drug Historic Market Size by Type (2015-2020)
4.2 Global NSAIDs Drug Forecasted Market Size by Type (2021-2026)
5 Market Size by Application (2015-2026)
5.1 Global NSAIDs Drug Market Size by Application (2015-2020)
5.2 Global NSAIDs Drug Forecasted Market Size by Application (2021-2026)
6 North America
6.1 North America NSAIDs Drug Market Size (2015-2020)
6.2 NSAIDs Drug Key Players in North America (2019-2020)
6.3 North America NSAIDs Drug Market Size by Type (2015-2020)
6.4 North America NSAIDs Drug Market Size by Application (2015-2020)
7 Europe
7.1 Europe NSAIDs Drug Market Size (2015-2020)
7.2 NSAIDs Drug Key Players in Europe (2019-2020)
7.3 Europe NSAIDs Drug Market Size by Type (2015-2020)
7.4 Europe NSAIDs Drug Market Size by Application (2015-2020)
8 China
8.1 China NSAIDs Drug Market Size (2015-2020)
8.2 NSAIDs Drug Key Players in China (2019-2020)
8.3 China NSAIDs Drug Market Size by Type (2015-2020)
8.4 China NSAIDs Drug Market Size by Application (2015-2020)
9 Japan
9.1 Japan NSAIDs Drug Market Size (2015-2020)
9.2 NSAIDs Drug Key Players in Japan (2019-2020)
9.3 Japan NSAIDs Drug Market Size by Type (2015-2020)
9.4 Japan NSAIDs Drug Market Size by Application (2015-2020)
10 Southeast Asia
10.1 Southeast Asia NSAIDs Drug Market Size (2015-2020)
10.2 NSAIDs Drug Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia NSAIDs Drug Market Size by Type (2015-2020)
10.4 Southeast Asia NSAIDs Drug Market Size by Application (2015-2020)
11 India
11.1 India NSAIDs Drug Market Size (2015-2020)
11.2 NSAIDs Drug Key Players in India (2019-2020)
11.3 India NSAIDs Drug Market Size by Type (2015-2020)
11.4 India NSAIDs Drug Market Size by Application (2015-2020)
12 Central & South America
12.1 Central & South America NSAIDs Drug Market Size (2015-2020)
12.2 NSAIDs Drug Key Players in Central & South America (2019-2020)
12.3 Central & South America NSAIDs Drug Market Size by Type (2015-2020)
12.4 Central & South America NSAIDs Drug Market Size by Application (2015-2020)
13 Key Players Profiles
13.1 Pfizer
13.1.1 Pfizer Company Details
13.1.2 Pfizer Business Overview
13.1.3 Pfizer NSAIDs Drug Introduction
13.1.4 Pfizer Revenue in NSAIDs Drug Business (2015-2020))
13.1.5 Pfizer Recent Development
13.2 GSK
13.2.1 GSK Company Details
13.2.2 GSK Business Overview
13.2.3 GSK NSAIDs Drug Introduction
13.2.4 GSK Revenue in NSAIDs Drug Business (2015-2020)
13.2.5 GSK Recent Development
13.3 Grunenthal
13.3.1 Grunenthal Company Details
13.3.2 Grunenthal Business Overview
13.3.3 Grunenthal NSAIDs Drug Introduction
13.3.4 Grunenthal Revenue in NSAIDs Drug Business (2015-2020)
13.3.5 Grunenthal Recent Development
13.4 Bayer
13.4.1 Bayer Company Details
13.4.2 Bayer Business Overview
13.4.3 Bayer NSAIDs Drug Introduction
13.4.4 Bayer Revenue in NSAIDs Drug Business (2015-2020)
13.4.5 Bayer Recent Development
13.5 Sanofi
13.5.1 Sanofi Company Details
13.5.2 Sanofi Business Overview
13.5.3 Sanofi NSAIDs Drug Introduction
13.5.4 Sanofi Revenue in NSAIDs Drug Business (2015-2020)
13.5.5 Sanofi Recent Development
13.6 Eli Lilly
13.6.1 Eli Lilly Company Details
13.6.2 Eli Lilly Business Overview
13.6.3 Eli Lilly NSAIDs Drug Introduction
13.6.4 Eli Lilly Revenue in NSAIDs Drug Business (2015-2020)
13.6.5 Eli Lilly Recent Development
13.7 AstraZeneca
13.7.1 AstraZeneca Company Details
13.7.2 AstraZeneca Business Overview
13.7.3 AstraZeneca NSAIDs Drug Introduction
13.7.4 AstraZeneca Revenue in NSAIDs Drug Business (2015-2020)
13.7.5 AstraZeneca Recent Development
13.8 Endo
13.8.1 Endo Company Details
13.8.2 Endo Business Overview
13.8.3 Endo NSAIDs Drug Introduction
13.8.4 Endo Revenue in NSAIDs Drug Business (2015-2020)
13.8.5 Endo Recent Development
13.9 Merck
13.9.1 Merck Company Details
13.9.2 Merck Business Overview
13.9.3 Merck NSAIDs Drug Introduction
13.9.4 Merck Revenue in NSAIDs Drug Business (2015-2020)
13.9.5 Merck Recent Development
13.10 Depomed
13.10.1 Depomed Company Details
13.10.2 Depomed Business Overview
13.10.3 Depomed NSAIDs Drug Introduction
13.10.4 Depomed Revenue in NSAIDs Drug Business (2015-2020)
13.10.5 Depomed Recent Development
13.11 Yunnan Baiyao
10.11.1 Yunnan Baiyao Company Details
10.11.2 Yunnan Baiyao Business Overview
10.11.3 Yunnan Baiyao NSAIDs Drug Introduction
10.11.4 Yunnan Baiyao Revenue in NSAIDs Drug Business (2015-2020)
10.11.5 Yunnan Baiyao Recent Development
13.12 Teva
10.12.1 Teva Company Details
10.12.2 Teva Business Overview
10.12.3 Teva NSAIDs Drug Introduction
10.12.4 Teva Revenue in NSAIDs Drug Business (2015-2020)
10.12.5 Teva Recent Development
13.13 J&J
10.13.1 J&J Company Details
10.13.2 J&J Business Overview
10.13.3 J&J NSAIDs Drug Introduction
10.13.4 J&J Revenue in NSAIDs Drug Business (2015-2020)
10.13.5 J&J Recent Development
13.14 Allergan
10.14.1 Allergan Company Details
10.14.2 Allergan Business Overview
10.14.3 Allergan NSAIDs Drug Introduction
10.14.4 Allergan Revenue in NSAIDs Drug Business (2015-2020)
10.14.5 Allergan Recent Development
13.15 Purdue
10.15.1 Purdue Company Details
10.15.2 Purdue Business Overview
10.15.3 Purdue NSAIDs Drug Introduction
10.15.4 Purdue Revenue in NSAIDs Drug Business (2015-2020)
10.15.5 Purdue Recent Development
14 Analyst’s Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details
Table 1. NSAIDs Drug Key Market Segments
Table 2. Key Players Covered: Ranking by NSAIDs Drug Revenue
Table 3. Ranking of Global Top NSAIDs Drug Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global NSAIDs Drug Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Ibuprofen
Table 6. Key Players of Naproxen
Table 7. Global NSAIDs Drug Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 8. Global NSAIDs Drug Market Size by Regions (US$ Million): 2020 VS 2026
Table 9. Global NSAIDs Drug Market Size by Regions (2015-2020) (US$ Million)
Table 10. Global NSAIDs Drug Market Share by Regions (2015-2020)
Table 11. Global NSAIDs Drug Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 12. Global NSAIDs Drug Market Share by Regions (2021-2026)
Table 13. Market Top Trends
Table 14. Key Drivers: Impact Analysis
Table 15. Key Challenges
Table 16. NSAIDs Drug Market Growth Strategy
Table 17. Main Points Interviewed from Key NSAIDs Drug Players
Table 18. Global NSAIDs Drug Revenue by Players (2015-2020) (Million US$)
Table 19. Global NSAIDs Drug Market Share by Players (2015-2020)
Table 20. Global Top NSAIDs Drug Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in NSAIDs Drug as of 2019)
Table 21. Global NSAIDs Drug by Players Market Concentration Ratio (CR5 and HHI)
Table 22. Key Players Headquarters and Area Served
Table 23. Key Players NSAIDs Drug Product Solution and Service
Table 24. Date of Enter into NSAIDs Drug Market
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global NSAIDs Drug Market Size by Type (2015-2020) (Million US$)
Table 27. Global NSAIDs Drug Market Size Share by Type (2015-2020)
Table 28. Global NSAIDs Drug Revenue Market Share by Type (2021-2026)
Table 29. Global NSAIDs Drug Market Size Share by Application (2015-2020)
Table 30. Global NSAIDs Drug Market Size by Application (2015-2020) (Million US$)
Table 31. Global NSAIDs Drug Market Size Share by Application (2021-2026)
Table 32. North America Key Players NSAIDs Drug Revenue (2019-2020) (Million US$)
Table 33. North America Key Players NSAIDs Drug Market Share (2019-2020)
Table 34. North America NSAIDs Drug Market Size by Type (2015-2020) (Million US$)
Table 35. North America NSAIDs Drug Market Share by Type (2015-2020)
Table 36. North America NSAIDs Drug Market Size by Application (2015-2020) (Million US$)
Table 37. North America NSAIDs Drug Market Share by Application (2015-2020)
Table 38. Europe Key Players NSAIDs Drug Revenue (2019-2020) (Million US$)
Table 39. Europe Key Players NSAIDs Drug Market Share (2019-2020)
Table 40. Europe NSAIDs Drug Market Size by Type (2015-2020) (Million US$)
Table 41. Europe NSAIDs Drug Market Share by Type (2015-2020)
Table 42. Europe NSAIDs Drug Market Size by Application (2015-2020) (Million US$)
Table 43. Europe NSAIDs Drug Market Share by Application (2015-2020)
Table 44. China Key Players NSAIDs Drug Revenue (2019-2020) (Million US$)
Table 45. China Key Players NSAIDs Drug Market Share (2019-2020)
Table 46. China NSAIDs Drug Market Size by Type (2015-2020) (Million US$)
Table 47. China NSAIDs Drug Market Share by Type (2015-2020)
Table 48. China NSAIDs Drug Market Size by Application (2015-2020) (Million US$)
Table 49. China NSAIDs Drug Market Share by Application (2015-2020)
Table 50. Japan Key Players NSAIDs Drug Revenue (2019-2020) (Million US$)
Table 51. Japan Key Players NSAIDs Drug Market Share (2019-2020)
Table 52. Japan NSAIDs Drug Market Size by Type (2015-2020) (Million US$)
Table 53. Japan NSAIDs Drug Market Share by Type (2015-2020)
Table 54. Japan NSAIDs Drug Market Size by Application (2015-2020) (Million US$)
Table 55. Japan NSAIDs Drug Market Share by Application (2015-2020)
Table 56. Southeast Asia Key Players NSAIDs Drug Revenue (2019-2020) (Million US$)
Table 57. Southeast Asia Key Players NSAIDs Drug Market Share (2019-2020)
Table 58. Southeast Asia NSAIDs Drug Market Size by Type (2015-2020) (Million US$)
Table 59. Southeast Asia NSAIDs Drug Market Share by Type (2015-2020)
Table 60. Southeast Asia NSAIDs Drug Market Size by Application (2015-2020) (Million US$)
Table 61. Southeast Asia NSAIDs Drug Market Share by Application (2015-2020)
Table 62. India Key Players NSAIDs Drug Revenue (2019-2020) (Million US$)
Table 63. India Key Players NSAIDs Drug Market Share (2019-2020)
Table 64. India NSAIDs Drug Market Size by Type (2015-2020) (Million US$)
Table 65. India NSAIDs Drug Market Share by Type (2015-2020)
Table 66. India NSAIDs Drug Market Size by Application (2015-2020) (Million US$)
Table 67. India NSAIDs Drug Market Share by Application (2015-2020)
Table 68. Central & South America Key Players NSAIDs Drug Revenue (2019-2020) (Million US$)
Table 69. Central & South America Key Players NSAIDs Drug Market Share (2019-2020)
Table 70. Central & South America NSAIDs Drug Market Size by Type (2015-2020) (Million US$)
Table 71. Central & South America NSAIDs Drug Market Share by Type (2015-2020)
Table 72. Central & South America NSAIDs Drug Market Size by Application (2015-2020) (Million US$)
Table 73. Central & South America NSAIDs Drug Market Share by Application (2015-2020)
Table 74. Pfizer Company Details
Table 75. Pfizer Business Overview
Table 76. Pfizer Product
Table 77. Pfizer Revenue in NSAIDs Drug Business (2015-2020) (Million US$)
Table 78. Pfizer Recent Development
Table 79. GSK Company Details
Table 80. GSK Business Overview
Table 81. GSK Product
Table 82. GSK Revenue in NSAIDs Drug Business (2015-2020) (Million US$)
Table 83. GSK Recent Development
Table 84. Grunenthal Company Details
Table 85. Grunenthal Business Overview
Table 86. Grunenthal Product
Table 87. Grunenthal Revenue in NSAIDs Drug Business (2015-2020) (Million US$)
Table 88. Grunenthal Recent Development
Table 89. Bayer Company Details
Table 90. Bayer Business Overview
Table 91. Bayer Product
Table 92. Bayer Revenue in NSAIDs Drug Business (2015-2020) (Million US$)
Table 93. Bayer Recent Development
Table 94. Sanofi Company Details
Table 95. Sanofi Business Overview
Table 96. Sanofi Product
Table 97. Sanofi Revenue in NSAIDs Drug Business (2015-2020) (Million US$)
Table 98. Sanofi Recent Development
Table 99. Eli Lilly Company Details
Table 100. Eli Lilly Business Overview
Table 101. Eli Lilly Product
Table 102. Eli Lilly Revenue in NSAIDs Drug Business (2015-2020) (Million US$)
Table 103. Eli Lilly Recent Development
Table 104. AstraZeneca Company Details
Table 105. AstraZeneca Business Overview
Table 106. AstraZeneca Product
Table 107. AstraZeneca Revenue in NSAIDs Drug Business (2015-2020) (Million US$)
Table 108. AstraZeneca Recent Development
Table 109. Endo Business Overview
Table 110. Endo Product
Table 111. Endo Company Details
Table 112. Endo Revenue in NSAIDs Drug Business (2015-2020) (Million US$)
Table 113. Endo Recent Development
Table 114. Merck Company Details
Table 115. Merck Business Overview
Table 116. Merck Product
Table 117. Merck Revenue in NSAIDs Drug Business (2015-2020) (Million US$)
Table 118. Merck Recent Development
Table 119. Depomed Company Details
Table 120. Depomed Business Overview
Table 121. Depomed Product
Table 122. Depomed Revenue in NSAIDs Drug Business (2015-2020) (Million US$)
Table 123. Depomed Recent Development
Table 124. Yunnan Baiyao Company Details
Table 125. Yunnan Baiyao Business Overview
Table 126. Yunnan Baiyao Product
Table 127. Yunnan Baiyao Revenue in NSAIDs Drug Business (2015-2020) (Million US$)
Table 128. Yunnan Baiyao Recent Development
Table 129. Teva Company Details
Table 130. Teva Business Overview
Table 131. Teva Product
Table 132. Teva Revenue in NSAIDs Drug Business (2015-2020) (Million US$)
Table 133. Teva Recent Development
Table 134. J&J Company Details
Table 135. J&J Business Overview
Table 136. J&J Product
Table 137. J&J Revenue in NSAIDs Drug Business (2015-2020) (Million US$)
Table 138. J&J Recent Development
Table 139. Allergan Company Details
Table 140. Allergan Business Overview
Table 141. Allergan Product
Table 142. Allergan Revenue in NSAIDs Drug Business (2015-2020) (Million US$)
Table 143. Allergan Recent Development
Table 144. Purdue Company Details
Table 145. Purdue Business Overview
Table 146. Purdue Product
Table 147. Purdue Revenue in NSAIDs Drug Business (2015-2020) (Million US$)
Table 148. Purdue Recent Development
Table 149. Research Programs/Design for This Report
Table 150. Key Data Information from Secondary Sources
Table 151. Key Data Information from Primary Sources
List of Figures
Figure 1. Global NSAIDs Drug Market Share by Type: 2020 VS 2026
Figure 2. Ibuprofen Features
Figure 3. Naproxen Features
Figure 4. Global NSAIDs Drug Market Share by Application: 2020 VS 2026
Figure 5. Hospitals Case Studies
Figure 6. Clinics Case Studies
Figure 7. Drugstores Case Studies
Figure 8. NSAIDs Drug Report Years Considered
Figure 9. Global NSAIDs Drug Market Size YoY Growth 2015-2026 (US$ Million)
Figure 10. Global NSAIDs Drug Market Share by Regions: 2020 VS 2026
Figure 11. Global NSAIDs Drug Market Share by Regions (2021-2026)
Figure 12. Porter's Five Forces Analysis
Figure 13. Global NSAIDs Drug Market Share by Players in 2019
Figure 14. Global Top NSAIDs Drug Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in NSAIDs Drug as of 2019
Figure 15. The Top 10 and 5 Players Market Share by NSAIDs Drug Revenue in 2019
Figure 16. North America NSAIDs Drug Market Size YoY Growth (2015-2020) (Million US$)
Figure 17. Europe NSAIDs Drug Market Size YoY Growth (2015-2020) (Million US$)
Figure 18. China NSAIDs Drug Market Size YoY Growth (2015-2020) (Million US$)
Figure 19. Japan NSAIDs Drug Market Size YoY Growth (2015-2020) (Million US$)
Figure 20. Southeast Asia NSAIDs Drug Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. India NSAIDs Drug Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. Central & South America NSAIDs Drug Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. Bottom-up and Top-down Approaches for This Report
Figure 24. Data Triangulation
Figure 25. Key Executives Interviewed
非ステロイド性抗炎症薬（NSAID）の世界市場（～2026年） Nonsteroidal anti-inflammatory drugs (NSAIDs) are a drug class that reduce pain, decrease fever, prevent blood clots and, in higher doses, decrease inflammation. Side effects depend on the specific drug, but largely include an increased risk of gastrointestinal ulcers and bleeds, heart attack and ki…- 関節炎薬の世界市場（～2026年） Arthritis is condition that causes pain and inflammation in joints. Around 100 different types of arthritis related conditions present globally and it is one of the leading cause of disability worldwide. The most common types of arthritis includes: Psoriatic Arthritis, Rheumatoid Arthritis, Osteoart…
- 創薬アウトソーシングの世界市場（～2026年） Over the last two decades, the Pharmaceutical industry has seen a radical change. The unprecedented downsizing of the internal discovery of big pharmaceuticals, patent expiration, shift towards biologics have seen a surge in the externalization and outsourcing activities. As the industry is looking …
- 小売薬の世界市場（～2026年） A drug is any substance (other than food that provides nutritional support) that, when inhaled, injected, smoked, consumed, absorbed via a patch on the skin, or dissolved under the tongue causes a temporary physiological (and often psychological) change in the body. Increasing industry share of Asia…
- 深部静脈血栓症（DVT）治療薬の世界市場（～2026年） Market Analysis and Insights: Global Deep Vein Thrombosis (DVT) Drug Market The global Deep Vein Thrombosis (DVT) Drug market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Deep Vein Thrombosis (DVT) Drug Scope and Market Si…